scispace - formally typeset
Open AccessJournal ArticleDOI

Myoclonus and cerebellar ataxia following Coronavirus Disease 2019 (COVID-19).

Reads0
Chats0
TLDR
Within the movement disorder spectrum, myoclonus has been observed as a COVID-19-related feature in several patients, and different neurological symptoms have been described, either directly or indirectly caused by CO VID-19.
Abstract
The Coronavirus disease 2019 (COVID-19) outbreak has led to a pandemic with an overwhelming impact on daily living and the health care system. Major life-threatening complications may occur [1]. Although most patients suffer from respiratory symptoms, different neurological symptoms have been described, either directly or indirectly caused by COVID-19 [2]. Within the movement disorder spectrum, myoclonus has been observed as a COVID-19-related feature in several patients [3-5].

read more

Citations
More filters
Journal ArticleDOI

Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review.

TL;DR: A case and systematic review of myoclonus and cerebellar ataxia associated with COVID-19 is presented in this paper, where the authors identify 51 cases associated with the coronavirus disease 2019 pandemic.
Journal ArticleDOI

Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.

TL;DR: Clinification of the pathogenic mechanisms of SARS-CoV-2 is needed to encourage prompt diagnosis and optimized care, and identifying the presence of cytokine storm in patients with neurological COVID-19 manifestations will facilitate avenues for treatment.
Journal ArticleDOI

Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.

TL;DR: Seven cases of opsoclonus-myoclonu syndrome presumably para-infectious in nature are reported and their phenomenology, their possible pathophysiological relationship to COVID-19 and diagnostic and treatment strategy in each case are discussed.
Journal ArticleDOI

New-Onset Movement Disorders Associated with COVID-19.

TL;DR: In this article, the authors identified 93 new-onset movement disorders cases (44 articles) from 200 articles screened in the PubMed/MEDLINE database or reference lists, including myoclonus was present in 63.4% (n = 59), ataxia in 38.7%, rigid-akinetic syndrome in 5.4%, dystonia in 1.1%, chorea in 1, and functional (psychogenic) movement disorders in 3.78%.
Journal ArticleDOI

De Novo Movement Disorders and COVID-19: Exploring the Interface.

TL;DR: Neurological manifestations of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) are being widely documented but movement disorders in the setting of 2019 coronav virus infectious disease (COVID‐19) have been a strikingly less discussed topic.
References
More filters

WHO Declares COVID-19 a Pandemic.

TL;DR: The Director-General of the World Health Organization, Dr. Tedros Adhanom Ghebreyesus, noted that over the past 2 weeks, the number of cases outside China increased 13-fold and theNumber of countries with cases increased threefold, and further increases are expected.
Journal ArticleDOI

Neurological Associations of COVID-19

TL;DR: The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of a scale not seen since the 1918 influenza pandemic and the proportion of infections leading to neurological disease will probably remain small.
Journal ArticleDOI

Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement.

TL;DR: Delirium should be recognized as a potential feature of infection with SARS-CoV-2 and may be the only presenting symptom, and hospitals should consider adding mental status changes to the list of testing criteria.
Journal ArticleDOI

Generalized myoclonus in COVID-19.

TL;DR: The 3 cases highlight the occurrence of myoclonus during the COVID-19 pandemic as a post- or para-infectious immune-mediated disorder, however, it cannot rule out that SARS-CoV-2 may spread transneuronally to first- and second-order structures connected with the olfactory bulb.
Journal ArticleDOI

Postinfectious brainstem encephalitis associated with SARS-CoV-2.

TL;DR: Clinical improvement was seen following corticosteroids, highlighting this as a possible treatment in patients where a post-CO VID-19 autoimmune encephalitis is suspected, and a postinfectious brainstem syndrome in a patient with COVID-19 who presented with generalised myoclonus, ocular flutter with convergence spasm and acquired hyperekplexia.
Related Papers (5)

The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.

Ross W. Paterson, +74 more
- 01 Oct 2020 -